PHASE IIIB, DOUBLE BLIND MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALTEPLASE IN PATIENTS WITH MILD STROKE: RAPIDLY IMPROVING SYMPTOMS AND MINOR NEUROLOGIC DEFICITS (PRISMS)
Principal Investigator(s)
Misra,Vivek
Funded by
GENENTECH INCORPORATED
Research Start Date
Status
Active